A shared story looks at which wellness products, peptides among them, can lead to positive doping tests for athletes.
Recap by typeshit. Post by @MarktheSpaman on X.
He describes a case where a product sourced from neither Eli Lilly nor a compounding pharmacy was followed by liver failure within six days.
The pharmacists' group says the drug looks promising but urges patients to understand what they risk with unofficial sources, and points to its SafeMedication site.
The pharmacists' group points people to its SafeMedication site for a patient-friendly explainer on retatrutide and why unofficial sources are risky.
He says the woman's retatrutide came from neither Lilly nor a compounding pharmacy, and her liver failed within six days of starting it.
Dr. Ambreen Roshan reminds patients to stick to the plan their own physician prescribes rather than adjusting tirzepatide themselves.
Mgoes highlights the figures, including up to 30% at two years in the extension. The drug is still in phase 3 and not approved.
Loading…